Fintel reports that on July 8, 2025, Scotiabank downgraded their outlook for Sage Therapeutics (NasdaqGM:SAGE) from Sector ...

A month has gone by since the last earnings report for Sage Therapeutics, Inc. (SAGE). Shares have lost about 11.1% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Monday was a dark day for Sage Therapeutics (SAGE-0.98%), a company that focuses on developing therapies for brain disorders.The stock plummeted by more than 53% after the company revealed that ...

Sage Therapeutics (NASDAQ:SAGE) will release its quarterly earnings report on Tuesday, 2025-04-29. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Sage ...

Sage Therapeutics, Inc. SAGE is focused on developing life-changing brain health medicines. In July, Sage Therapeutics and partner Biogen BIIB announced top-line data from the phase II KINETIC 2 ...

Sage Therapeutics (Sage) is an innovative biopharmaceutical company headquartered in Cambridge, Massachusetts. It focuses on the discovery and development of treatments for people with brain ...

Sage Therapeutics is no exception, as the company typically generates no more than a few million dollars in revenue each quarter. Last quarter, for the period ending June 30, ...

During the last three months, 5 analysts shared their evaluations of Sage Therapeutics (NASDAQ:SAGE), revealing diverse outlooks from bullish to bearish. Summarizing their recent assessments, the ...

Throughout the last three months, 17 analysts have evaluated Sage Therapeutics (NASDAQ:SAGE), offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ...

Sage Therapeutics said on Thursday that it plans to lay off about 40 percent of its workforce, roughly 275 employees, and shake up its leadership team following a decision by federal regulators ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today the presentation ...